Sickle cell screening in Uganda: High burden, human immunodeficiency virus comorbidity, and genetic modifiers

Abstract

High sickle cell burden and potential HIV comorbidity are confirmed in Uganda. Genetic modifiers are common and likely influence laboratory and clinical phenotypes. These prospective data document that targeted sickle cell screening is feasible and effective in Uganda, and support development of district-level comprehensive care programs.